Showing results (121-130 of 146) with videos related to

Sort By:
Pageof 15
Reproductive Sciences (Thousand Oaks, Calif.)|October 5, 2010
Effects of triclocarban on intact immature male rat: augmentation of androgen actionAntoni J Duleba, Mohamed I Ahmed, Meng Sun, et al.
Thoracic Cancer|November 1, 2011
A proteomic approach to elucidate the multiple targets of selenium-induced cell-growth inhibition in human lung cancerXiaorong Zhong, Lu Li, Min Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2020
Steroid Sulfatase Stimulates Intracrine Androgen Synthesis and is a Therapeutic Target for Advanced Prostate CancerCameron M Armstrong, Chengfei Liu, Liangren Liu, et al.
Oncogene|July 17, 2021
ARVib suppresses growth of advanced prostate cancer via inhibition of androgen receptor signalingChengfei Liu, Cameron M Armstrong, Shu Ning, et al.
Molecular Cancer Therapeutics|December 5, 2025
IGFBP3-SphK1/S1P Signaling Axis Drives Enzalutamide Resistance in Advanced Prostate CancerAmy R Leslie, Shu Ning, Masuda Sharifi, et al.
Plos One|April 6, 2012
MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growthNagalakshmi Nadiminty, Ramakumar Tummala, Wei Lou, et al.
Oncogene|January 3, 2023
Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancerJoy C Yang, Pengfei Xu, Shu Ning, et al.
Nature Communications|November 18, 2018
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancerChengfei Liu, Wei Lou, Joy C Yang, et al.
Nature Genetics|March 8, 2005
Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancerXiaodong Sun, Henry F Frierson, Ceshi Chen, et al.
Molecular Cancer Therapeutics|May 5, 2026
Targeting NDUFS4 Disrupts Oxidative Phosphorylation and Induces Ferroptosis in Olaparib-Resistant Prostate CancerZachary A Schaaf, Shu Ning, Amy R Leslie, et al.
Pageof 15